Condition
Transfusion Dependent Thalassemia clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Transfusion Dependent Thalassemia clinical trials that are recruiting, in China. By phase: Phase 2 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
Using a monoclonal antibody to prevent graft-versus-host disease in thalassemia patients after stem cell transplantation
This study is testing if a new antibody can help prevent graft-versus-host disease in thalassemia patients who are receiving stem cell transplants.
-
Evaluating GMCN-508A for treating transfusion-dependent α-thalassemia
This study is testing a new treatment using a patient's own stem cells to see if it can help young people with transfusion-dependent α-thalassemia live healthier lives.
Quick answers
How many Transfusion Dependent Thalassemia clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.